Kriya Therapeutics: Gene Therapy. Redefined.
Kriya is targeting diseases that impact millions of people worldwide and represent areas of high unmet need. We target validated biological pathways with innovative gene therapy approaches that have …
Our Team: Leaders in Gene Therapy - Kriya Therapeutics
Kriya’s team of gene therapy pioneers and biopharma veterans is building a pipeline to address common diseases.
Pipeline - Kriya Therapeutics
Kriya is developing a portfolio of one-time gene therapies in ophthalmology, metabolic disease and neurology.
Newsroom: Gene Therapy Pipeline News - Kriya Therapeutics
Sep 12, 2024 · Kriya shares the latest news on our pipeline of life-changing gene therapies to address common diseases.
Careers: Future of Gene Therapy - Kriya Therapeutics
Careers Kriya is Changing the Future of Gene Therapy We have an ambitious set of goals, but our confidence – and our inspiration – stems from our people. From California to North Carolina, our …
Kriya Presents Data at the 2025 Association for Research in Vision and ...
Kriya is developing KRIYA-825, a potential one-time gene therapy for Geographic Atrophy (GA) that expresses a fusion protein designed to inhibit the activity of complement C3 and C5, with the …
Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene ...
Sep 12, 2024 · KRIYA-586 is an investigational adeno-associated virus (AAV) gene therapy product engineered to express an antibody that inhibits Insulin-Like Growth Factor 1 Receptor (IGF1R), a key …
Metabolic Disease: Gene Therapy for Diabetes and NASH - Kriya …
Kriya is developing KRIYA 839, a potential one-time gene therapy for type 1 diabetes expressing insulin and glucokinase, designed to be delivered intramuscularly with the objective of driving durable …
Kriya Announces $150 Million Addition to its Series C, Bringing Total ...
Jul 26, 2023 · With operations in Palo Alto, California and Research Triangle Park, North Carolina, Kriya has raised over $600 million in committed capital, which will be used to advance a broad pipeline of …
Kriya Provides Update on Pipeline Progress Ahead of Company ...
Jan 8, 2024 · Kriya has designed KRIYA-839 for diabetes with the following potential goals in mind: Robust glycemic control: Improving time-in-range and lowering HbA1c to reduce the risk of long-term …